subscribe
 

New vaccine to combat Aussie flu

Seqirus to commercialise novel cell-based quadrivalent influenza vaccine in Europe



New vaccine to combat Aussie flue

Seqirus to commercialise novel cell-based quadrivalent influenza vaccine in Europe



New vaccine to combat Aussie flue

Seqirus to commercialise novel cell-based quadrivalent influenza vaccine in Europe



Fighting Influenza A (H7N9) Virus

Human infections with H7N9 flu first emerged in China in March 2013 and since then, China has reported cases of human H7N9 infection to the The World Health Organization (WHO). Human infections with other subgroups of H7 influenza viruses (H7N2, H7N3 and H7N7) have previously been reported in the Netherlands, Italy, Canada, United States of America, Mexico and the United Kingdom.




Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea

Next-generation therapeutics for infectious diseases conquer the global spotlight, finds Frost & Sullivan



Double dose of antiviral drug offers no added benefit in severe influenza

Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe influenza infection



H1N1 vaccine protects against 1918 influenza virus

Researchers have determined people who were vaccinated against the 2009 H1N1 influenza virus may also be protected against the lethal 1918 Spanish influenza virus, which killed more than 50 million people worldwide.



Equitable access to influenza vaccines not in sight

A recent article provides a case study of the negotiations to increase access to vaccines for influenza strains that suggest the goal of equitable access is far from certain.



Household transmission of H1N1 Influenza

Simple, common sense behaviours, including having a discussion at home about how to prevent influenza, can help limit the spread of H1N1 in a household, according to a study.



H1N1 influenza virus damages entire airway

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics, report researchers.



H1N1 influenza vaccine trial in people with asthma

The NIH is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma.



Trials of 2009 H1N1 influenza vaccines in healthy adults

The early data from clinical trials indicate that 2009 H1N1 influenza vaccines are well tolerated and induce a strong immune response in most healthy adults when administered in a single unadjuvanted 15-microgram dose.



Universal influenza vaccination may reduce antibiotic use

Influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use.



Biotechnology: Influenza monitoring by the US military

Researchers describe a program that has repeatedly made notable contributions to global influenza control through close collaboration with CDC, FDA, the WHO, and many other partners.



Influenza virus in 1918 and today

Scientists argue that we have lived in an influenza pandemic era since 1918, and they describe how the novel 2009 H1N1 virus is yet another manifestation of this enduring viral family.



Influenza outbreaks in birds

New data on the persistence of avian influenza viruses in the environment has allowed researchers to create the first model that takes into account both direct and indirect transmission of the viruses among birds.



Preventing the spread of influenza

Research results show that face protection is a key infection control measure for influenza and can thus affect how people should try to protect themselves from the swine flu.



Mechanism that allows influenza invasion

Researchers at the University of Southern California have identified a critical molecular mechanism that allows the influenza virus to evade the body's immune response system.



Protection against pandemic influenza

A novel vaccine strategy using virus-like particles could provide stronger and longer-lasting influenza vaccines with a significantly shorter development and production time than current ones.



Influenza pandemic planning needed

Pregnant women and newborns are at greatest risk in a flu epidemic, but more planning must be done to ensure that they receive priority treatment should an outbreak occur, according to a recent study.



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe